You just read:

MGB Biopharma Commences Phase I Clinical Trial With Oral Formulation of MGB-BP-3 for the Treatment of Multi-Resistant Clostridium Difficile Infections

News provided by

MGB Biopharma

Jul 21, 2015, 04:00 ET